Company / EPS (Diluted)
Dare Bioscience, Inc. EPS (Diluted) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.48
FY2025
5-year range
-$4.15 / -$0.37
FY2021-FY2025
Trend
+88.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.37 to $-0.48 over the past 2 years.
Based on SEC 10-K filings.
-0.48 in FY2025.
Declined from $-0.37 to $-0.48 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 88.4% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.48 | +88.4% |
| FY2024 | -$4.15 | -1021.6% |
| FY2023 | -$0.37 | +41.3% |
| FY2022 | -$0.63 | +60.6% |
| FY2016 | -$1.60 | +93.6% |
| FY2015 | -$25.05 | +31.2% |
| FY2014 | -$36.39 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026